Acquiring Company
Aurobindo Pharma Limited
Acquired Company
A1 Biochem Group
Description
Aurobindo Pharma Limited's subsidiary, Apitoria Pharma, has acquired an 80% stake in A1 Biochem Group's CRO business for USD 17 million. This acquisition will enable Aurobindo to enhance its research and development capabilities while expanding its presence in the Active Pharmaceutical Ingredients market. The deal is expected to close within 90 to 120 days, pending regulatory approvals.
Quick answer
Aurobindo Pharma Limited is acquiring A1 Biochem Group, announced July 23, 2026. Aurobindo Pharma Limited is based in United States.
- How much did Aurobindo Pharma Limited pay for A1 Biochem Group?
- The deal value was not disclosed.
- What does Aurobindo Pharma Limited do?
- Aurobindo Pharma Limited is a Midcap Pharma stock engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services.
- Where are Aurobindo Pharma Limited and A1 Biochem Group based?
- Aurobindo Pharma Limited is based in United States. A1 Biochem Group is based in Hyderabad, Telangana, India.
- Who are the decision-makers at Aurobindo Pharma Limited?
- Fundz holds 1 contact at Aurobindo Pharma Limited. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Senores Pharma acquires 75% stake in Apnar Pharma (August 30, 2026)
- Medios acquires 74% of Caelo to enhance growth (August 12, 2026)
- Towa Pharmaceutical acquires Tanabe's plants (July 8, 2026)
- Bora Pharmaceuticals acquires MacroGenics' operations (July 2, 2026)
- Ipca Laboratories to merge with Krebs Biochemicals (June 26, 2026)
- Laprophan Acquires Rivopharm for European Expansion (June 17, 2026)
Who to call at Aurobindo Pharma Limited, and when
When Aurobindo Pharma Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Aurobindo Pharma Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aurobindo Pharma Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aurobindo Pharma Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aurobindo Pharma Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired A1 Biochem Group?
A1 Biochem Group was acquired by Aurobindo Pharma Limited, based in United States. The deal was reported on July 23, 2026. Aurobindo Pharma Limited is a Midcap Pharma stock engaged in the manufacturing and marketing of APIs, generic pharmaceuticals, and other related services. Aurobindo Pharma Limited is privately held and operates in Manufacturing.
When did Aurobindo Pharma Limited acquire A1 Biochem Group?
Aurobindo Pharma Limited's acquisition of A1 Biochem Group was reported on July 23, 2026. Aurobindo Pharma Limited's subsidiary, Apitoria Pharma, has acquired an 80% stake in A1 Biochem Group's CRO business for USD 17 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does A1 Biochem Group do?
A1 Biochem Group is a Contract Research Organization (CRO) that offers comprehensive chemistry services to pharmaceutical companies and academic institutions. It is privately held, operating in Biotechnology, and is based in Hyderabad.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.